Valneva SE
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
other
SEC Category
Accelerated filer
State of Incorporation
France
Business Address
6, RUE ALAIN BOMBARD, SAINT-HERBLAIN, I0, 44800
Mailing Address
6, RUE ALAIN BOMBARD, SAINT-HERBLAIN, I0, 44800
Phone
33 2 28 07 37 10
Fiscal Year End
1231
EIN
000000000
Financial Overview
FY2025
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 6-K Foreign company current report | March 26, 2026 | View on SEC |
| 6-K Foreign company current report | March 23, 2026 | View on SEC |
| 6-K Foreign company current report | March 18, 2026 | View on SEC |
| 20-F Foreign company annual report | March 17, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | March 10, 2026 | View on SEC |
| 6-K Foreign company current report | March 9, 2026 | View on SEC |
| 6-K Foreign company current report | March 2, 2026 | View on SEC |
| 6-K Foreign company current report | February 19, 2026 | View on SEC |
| 6-K Foreign company current report | February 13, 2026 | View on SEC |
| 6-K Foreign company current report | February 3, 2026 | View on SEC |
Annual Reports
20-F
March 17, 2026
- U.S. FDA approval of IXCHIQ, the world's first Chikungunya vaccine, opening doors for commercialization in the U.S. and other territories.
- Lyme disease vaccine (VLA15) remains a cornerstone, undergoing Phase 3 clinical trials with Pfizer, with data readouts expected in the near future.
Related Companies
Companies in the same industry (SIC: 2836)
Adaptive Biotechnologies Corp
ADPT
Biological Products, (No Diagnostic Substances)
Voyager Therapeutics, Inc.
VYGR
Biological Products, (No Diagnostic Substances)
Immunovant, Inc.
IMVT
Biological Products, (No Diagnostic Substances)
Cardiff Oncology, Inc.
CRDF
Biological Products, (No Diagnostic Substances)
Kodiak Sciences Inc.
KOD
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.